Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.84
-0.0203-1.09%
Volume:887.14K
Turnover:1.64M
Market Cap:68.85M
PE:-1.25
High:1.91
Open:1.86
Low:1.80
Close:1.86
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:1.18
T/O Rate:5.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.61
PE(LYR):-1.37

Loading ...

Tenax Therapeutics CFO Thomas R. Staab II files initial beneficial ownership statement

Reuters
·
May 14

Tenax Therapeutics: Buy Rating Reiterated with $27 Price Target Unchanged on Compelling Phase 3 Opportunity

TIPRANKS
·
May 13

Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)

TIPRANKS
·
May 12

Tenax Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Tenax Therapeutics Q1 Net Income USD -15.716 Million

Reuters
·
May 12

Tenax Therapeutics Q1 net loss widens on higher R&D costs

Reuters
·
May 12

Tenax Therapeutics Q1 EPS $(0.35) Beats $(0.58) Estimate

Benzinga Earnings
·
May 12

Tenax Therapeutics Q1 EPS USD -0.35

THOMSON REUTERS
·
May 12

Tenax Therapeutics Q1 Operating Income USD -16.573 Million

THOMSON REUTERS
·
May 12

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Tenax Therapeutics (TENX) and Compass Therapeutics (CMPX)

TIPRANKS
·
May 10

Tenax Therapeutics awards inducement options for 657,500 shares to new hires

Reuters
·
May 09

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 09

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 09

Tenax Therapeutics appoints Timothy Healey chief commercial officer

Reuters
·
May 04

Tenax Therapeutics Names New CFO to Support Growth

TIPRANKS
·
Apr 22

Tenax Therapeutics announces annual shareholder meeting

Reuters
·
Apr 22

Tenax Therapeutics names Thomas R. Staab CFO, replacing interim CFO Thomas McGauley

Reuters
·
Apr 22

Tenax Therapeutics Inc - Thomas R. Staab, Ii Replaces Thomas Mcgauley as CFO

THOMSON REUTERS
·
Apr 22

Tenax Therapeutics Appoints Thomas R. Staab, Ii as Chief Financial Officer

THOMSON REUTERS
·
Apr 22

Press Release: Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Dow Jones
·
Apr 22